• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Peroral administration of 14C-poly(D,L-lactic acid) nanoparticles coated with human serum albumin or polyvinyl alcohol to guinea pigs.

作者信息

Landry F B, Bazile D V, Spenlehauer G, Veillard M, Kreuter J

机构信息

Institut für Pharmazeutische Technologie der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany.

出版信息

J Drug Target. 1998;6(4):293-307. doi: 10.3109/10611869808996837.

DOI:10.3109/10611869808996837
PMID:9894697
Abstract

Biodegradable 14C-poly(D,L-lactic acid) (PLA50) nanoparticles coated either with a readily digestible protein albumin or with a non-digestible coating agent, polyvinyl alcohol (PVA), were prepared by the solvent evaporation technique. The nanoparticles were administered perorally to guinea pigs to evaluate the gastro-intestinal degradation of their PLA50 matrix. In the case of PLA50 nanoparticles coated with digestible albumin, substantial gastro-intestinal degradation of the PLA50 matrix occurred, leading to the passage of considerable amount (> or =45%) of water-soluble products across the gastrointestinal barrier. When a non-digestible coating agent like PVA was used, the degradation of the PLA50 matrix in the gastro-intestinal tract was at least two times lower (> or =19%). The results show that it is possible to control the in vivo degradation of PLA50 nanoparticles using appropriate coating agents. The present investigations showed a good correlation between previously observed in vitro results and the in vivo findings.

摘要

相似文献

1
Peroral administration of 14C-poly(D,L-lactic acid) nanoparticles coated with human serum albumin or polyvinyl alcohol to guinea pigs.
J Drug Target. 1998;6(4):293-307. doi: 10.3109/10611869808996837.
2
Degradation of poly(D,L-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII).
Biomaterials. 1996 Apr;17(7):715-23. doi: 10.1016/0142-9612(96)86742-1.
3
Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats.
Biomaterials. 1992;13(15):1093-102. doi: 10.1016/0142-9612(92)90142-b.
4
Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process.通过溶剂蒸发法制备的聚乳酸纳米颗粒表面人血清白蛋白的吸附/解吸
J Biomed Mater Res. 1993 Aug;27(8):1019-28. doi: 10.1002/jbm.820270807.
5
Hydrolytic degradation of films prepared from blends of high and low molecular weight poly(DL-lactic acid)s.由高分子量和低分子量聚(DL-乳酸)共混物制备的薄膜的水解降解
J Biomed Mater Res. 1996 Feb;30(2):201-7. doi: 10.1002/(SICI)1097-4636(199602)30:2<201::AID-JBM10>3.0.CO;2-P.
6
Preparation and characterization of oil-in-water type poly (D,L-lactic acid) microspheres containing testosterone enanthate.含庚酸睾酮的水包油型聚(D,L-乳酸)微球的制备与表征
Drug Dev Ind Pharm. 1998 Oct;24(10):927-34. doi: 10.3109/03639049809097272.
7
In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles.生物相容性负电荷沙丁胺醇载药纳米粒的体外和体内性能。
J Control Release. 2010 Jan 4;141(1):101-7. doi: 10.1016/j.jconrel.2009.08.021. Epub 2009 Aug 29.
8
Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.用于心血管再狭窄治疗的维生素E TPGS乳化聚乳酸-乙醇酸共聚物纳米粒
Nanomedicine (Lond). 2007 Jun;2(3):333-44. doi: 10.2217/17435889.2.3.333.
9
Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.由聚乙烯醇接枝聚丙交酯乙交酯共聚物组成的紫杉醇释放膜及其作为可生物降解支架涂层的潜力。
J Control Release. 2006 Mar 10;111(1-2):235-46. doi: 10.1016/j.jconrel.2005.12.012. Epub 2006 Feb 8.
10
Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
J Microencapsul. 1993 Oct-Dec;10(4):449-60. doi: 10.3109/02652049309015322.

引用本文的文献

1
Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density.聚乙二醇接枝长循环纳米胶囊在小鼠体内的生物分布:聚乙二醇链长度和密度的影响
Pharm Res. 2001 Oct;18(10):1411-9. doi: 10.1023/a:1012248721523.